00000nam 2200000zi 4500 9.932074 CaOODSP 20250505145137 m o d f cr mn||||||||| 240104e201405##oncad ob f|0| 0 eng d CaOODSP eng rda CaOODSP n-cn--- H14-491/2014E-PDF Evaluation of the Biologics Program 1999-2000 to 2012-2013 / prepared by Evaluation Directorate, Health Canada and the Public Health Agency of Canada. [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, May 2014. 1 online resource (xx, 150 pages) : illustrations, graphs text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Évaluation du Programme des produits biologiques de 1999-2000 à 2012-2013. Includes bibliographical references (pages 121-130, pages 148-150). "The Biologics Program (BP) is managed through the Health Products and Food Branch (HPFB) of Health Canada. The BP regulates drugs and products derived from living sources, as well as radiopharmaceuticals. Products derived from living sources include blood and blood components and blood products; vaccines; hormones; enzymes; cytokines; monoclonal antibodies; gene therapy products; cells, tissues, and organs; xenografts; and semen for assisted conception"--Executive summary, page ii. Biologicals Canada Evaluation. Biologicals Risk assessment Canada. Canada. Health Canada. Evaluation Directorate, issuing body. Public Health Agency of Canada. Evaluation Directorate, issuing body. Évaluation du Programme des produits biologiques de 1999-2000 à 2012-2013 / (CaOODSP)9.935132 PDF 840 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H14-491-2014-eng.pdf